Verve Therapeutics, Inc.
USD11.13
+0.03 (+0.27%)
CEO
Sekar Kathiresan
IPO Date
2021-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.13
Prev. Close
$11.10
Day Low
$11.13
Day High
$11.13
52W Low
$2.87
52W High
$11.40
Market Cap
$0.99B
Volume
10.31M
| -4.5 |
| 31 Dec 2022 | FY | 100.0% | -8108.6% | -28.6% | -23.2% | 0.15 | 16.05 | -6.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -33.2% | -30.9% | 0.01 | 16.67 | -15.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 71.3% | -58.1% | -1.96 | 10.11 | -33.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 97.3% | -87.9% | -1.79 | 5.36 | -49.0 |
| -2.4 |
| 30 Sept 2024 | Q3 | 100.0% | -730.3% | -9.9% | -7.6% | 0.14 | 13.05 | -2.0 |
| 30 Jun 2024 | Q2 | 100.0% | -744.2% | -9.1% | -7.1% | 0.13 | 14.64 | -2.1 |
| 31 Mar 2024 | Q1 | 100.0% | -855.8% | -8.4% | -6.7% | 0.13 | 19.82 | -5.5 |
| 31 Dec 2023 | Q4 | 100.0% | -940.0% | -8.1% | -6.4% | 0.12 | 17.24 | -5.0 |
| 30 Sept 2023 | Q3 | 0.0% | -1468.0% | -9.9% | -7.5% | 0.17 | 14.41 | -4.6 |
| 30 Jun 2023 | Q2 | 0.0% | -2579.2% | -11.6% | -9.2% | 0.17 | 14.32 | -5.4 |
| 31 Mar 2023 | Q1 | 0.0% | -3254.3% | -9.0% | -7.2% | 0.16 | 15.16 | -4.9 |
| 31 Dec 2022 | Q4 | 0.0% | -4059.8% | -7.5% | -6.0% | 0.15 | 16.05 | -7.2 |